Timely surveillance of Promotion and Deficiency data for all listed and OTC securities is critical for compliance departments.
In Q2 2025:
75.5% of notional activity in promoted securities occurred in Nasdaq listed securities, 21.1% in NYSE American, 3.1% in NYSE and 0.3% in OTC Market securities.
86% of Deficiencies were in Nasdaq listed securities, 9% in NYSE and 5% in NYSE American.
View the Q1 2025 Promotion and Deficiencies data here.
Reach out to our team to learn more about the OTC Markets Listed & OTC Compliance Analytics Products.
